Astra eyes record merger with drug rival Gilead: report
British pharmaceuticals group AstraZeneca has approached US rival Gilead Sciences over a possible record merger, Bloomberg reported, as the pair spearhead treatments for COVID-19.
Jun 8, 2020
0
1